SCHEMBL2641777

SCHEMBL2641777

CCCCCCC(C/C=C/CCCCCCCCO)O[Si](c1ccccc1)(c1ccccc1)C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
MAPK1 P28482 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C9 P11712 2/20 0.41
MTOR P42345 1/20 0.41
PMP22 Q01453 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALOX15 P16050 1/20 0.41
NFKB1 P19838 1/20 0.41
KDM4E B2RXH2 1/20 0.41
PLIN1 O60240 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
PLIN5 Q00G26 1/20 0.41
LTB4R Q15722 1/20 0.41
ABHD5 Q8WTS1 1/20 0.41
FFAR1 O14842 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36
SOAT2 O75908 1/20 0.35
SOAT1 P35610 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14935363 1.00 ALDH1A1 (0.41) ALDH1A1MAPK1CYP3A4CYP2C9MTOR
SCHEMBL2641862 1.00 ALDH1A1 (0.41) ALDH1A1MAPK1CYP3A4CYP2C9MTOR
SCHEMBL2641780 1.00 ALDH1A1 (0.41) ALDH1A1MAPK1CYP3A4CYP2C9MTOR
SCHEMBL23387077 0.95 ALDH1A1 (0.37) ALDH1A1MAPK1CYP3A4CYP2C9MTOR
SCHEMBL29259357 0.95 ALDH1A1 (0.37) ALDH1A1MAPK1CYP3A4CYP2C9MTOR
SCHEMBL2636982 0.94 FFAR1 (0.36) ALDH1A1MAPK1CYP3A4CYP2C9MTOR
SCHEMBL2636981 0.94 FFAR1 (0.36) ALDH1A1MAPK1CYP3A4CYP2C9MTOR
SCHEMBL29770049 0.91 ALDH1A1 (0.40) ALDH1A1MAPK1CYP3A4CYP2C9MTOR
SCHEMBL14935308 0.90 FFAR1 (0.41) ALDH1A1MAPK1CYP3A4CYP2C9MTOR
SCHEMBL14946474 0.90 FFAR1 (0.41) ALDH1A1MAPK1CYP3A4CYP2C9MTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2569276-A1 NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOF Protiva Biotherapeutics Inc. (CA) 2013-03-20 EP disclosed
WO-2011141705-A1 NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOF PROTIVA BIOTHERAPEUTICS, INC. (CA) 2011-11-17 WO disclosed